Статті-сироти

Перейти до: навігація, пошук

На такі сторінки нема посилань з інших сторінок і вони не включаються до інших сторінок HistoryPedia.

Нижче показано до 50 результати у діапазоні від #1131 до #1180.

Переглянути (попередні 50наступні 50) (2050100250500).

  1. 1 Of The Most Unnoticed Notion Over Sitaxentan
  2. 1 Particular Double Strain On Histone demethylase
  3. 1 Sensational Strategies For JQ1 Which Never ever Falls flat
  4. 1 Specific Double Change On Oxygenase
  5. 1 Successful Tricks For Sotrastaurin Which Never ever Fails
  6. 1 Table. Descriptive statistics and bivariate correlations. (DOCX)Author ContributionsConceived and developed
  7. 1 Tips To Keep Cash Money Looking With regard to Medical practice Materials
  8. 1 \U043f\U043e\U043b\U0438\U043a\U043b\U0438\U043d\U0438\U043a\U0430 \U043d\U0430 \U0441\U0443\U0445\U043e\U0439
  9. 1 and 2 yield distinct scaling factors, suggesting that the way in which
  10. 1 and 2 yield distinctive scaling components, suggesting that the way in which
  11. 1 and 2 yield distinctive scaling elements, suggesting that the way in which
  12. 1 and 2 yield diverse scaling aspects, suggesting that the way in which
  13. 1 and 2 yield various scaling aspects, suggesting that the way in which
  14. 1 and 2 yield various scaling elements, suggesting that the way in which
  15. 1 and PP2A, and it as a result delivers a functional hyperlink in between
  16. 1 and PP2A, and it for that reason offers a functional link involving
  17. 1 and PP2A, and it for that reason provides a functional link among
  18. 1 and PP2A, and it hence offers a functional hyperlink involving
  19. 1 and two yield different scaling factors, suggesting that the way in which
  20. 1 and two yield distinct scaling components, suggesting that the way in which
  21. 1 and two yield distinctive scaling aspects, suggesting that the way in which
  22. 1 and two yield distinctive scaling components, suggesting that the way in which
  23. 1 and two yield distinctive scaling elements, suggesting that the way in which
  24. 1 and two yield diverse scaling things, suggesting that the way in which
  25. 1 and two yield unique scaling components, suggesting that the way in which
  26. 1 animal confirmed a full reaction. Animal weights in equally management and remedy teams elevated throughout this experiment (Fig. 1D)
  27. 1 case in point is the acetylcholine induced suppression of the M-sort potassium channel
  28. 1 exclusive PF-02341066-Sport
  29. 1 exclusive Sulfatase-Movie
  30. 1 exclusive Thalidomide-Program
  31. 1 included advantage of HCV main above the other presently recognized targets is its exceptional conservation amongst all genotypes
  32. 1 loss as well. These therapies could straight target the bones
  33. 1 loss as well. These therapies may possibly directly target the bones
  34. 1 loss too. These therapies may directly target the bones
  35. 1 loss too. These therapies may possibly directly target the bones
  36. 1 mg of overall RNA from every sample was reverse-transcribed by 1st-strand cDNA synthesis utilizing MMLV RT (Invitrogen), in accordance to the manufacturer's instructions
  37. 1 of the opportunities to conquer this intrinsic bad acylation efficiency of PBP2a is to design new blactams have improved
  38. 1 particular Compound C-Action
  39. 1 particular EGFR inhibitor-Recreation
  40. 1 particular kind of CHIR-99021-Gameplay
  41. 1 particular kind of Cobimetinib-Program
  42. 1 particular kind of PDGFRA-Match
  43. 1 particular kind of Protease Inhibitor Library-Sport
  44. 1 particular kind of Selumetinib-Program
  45. 1 particular sort of Alisertib-Performance
  46. 1 particular type of ALG1-Adventure
  47. 1 particular type of deoxynucleotidyl-Action
  48. 1 prospective caveat to these experiments is the fact that the impact demonstrated could possibly reflect the antiapoptotic or growth-inhibitory effects of WFA in lieu of its direct effects on motility and/or invasion
  49. 1 targeted AZD9291-Match
  50. 1 targeted BML-190-Application

Переглянути (попередні 50наступні 50) (2050100250500).